[mc4wp_form id="313"]

FDA Clears Novel ‘Recharge-Free’ Device for Chronic Pain

Share this post

Abbott’s Proclaim XR platform utilizes the company’s low energy BurstDR stimulation waveform to provide effective pain relief without the hassle of recharging for up to 10 years.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply